The Superintelligence Observer
The Next Web

INmune Bio and Quantum Computing Inc. partner on quantum optimization and AI for Alzheimer’s drug research

INmune Bio will combine its clinical research with QCi's Dirac-3S quantum optimization machine to look for new treatment indications and biomarkers for its drug XPro. The deal is QCi's first commercial customer in pharmaceuticals and biotech.

Related stories